Adjuvant intravesical bacillus Calmette-Guérin therapy and survival among elderly patients with non-muscle-invasive bladder cancer Academic Article uri icon

Overview

MeSH Major

  • Adjuvants, Immunologic
  • BCG Vaccine
  • Urinary Bladder Neoplasms

abstract

  • Despite guidelines recommending its use, BCG is administered to less than one quarter of eligible patients. This large population-based study found improved OS and BCSS were associated with use of adjuvant intravesical BCG among older patients with NMIBC. Better-designed clinical trials focusing on higher-grade cancers are needed to confirm these findings.

publication date

  • March 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3595445

Digital Object Identifier (DOI)

  • 10.1200/JOP.2011.000480

PubMed ID

  • 23814517

Additional Document Info

start page

  • 92

end page

  • 8

volume

  • 9

number

  • 2